Open Access

Figure 4.


Download original image

Antidepressant effects of Spadin. A) Forced Smimming Test (FST), spadin-treated mice have a shorter time of immobility comparable to that obtained with TREK-1 KO or fluoxetine-treated mice, whatever the way of spadin administration: intracerebroventricular (i.c.v), intravenous (i.v) or intraperitoneal (i.p). Acute treatments: Spadin (10−4 to 10−8 M) or Fluoxetine (3 mg/kg) or Saline solutions are injected 30 min before the test in wild-type and TREK-1 KO mice. B) Novelty-Suppressed Feeding Test (NSF): Subchronic treatments: Spadin (10−6 M), Fluoxetine (1 mg/kg) or Saline solutions are i.v. injected in a 100 μL bolus once a day for 4 successive days before the test. In chronic treatments, spadin (10−6 M) and fluoxetine (1 mg/kg) are i.v. injected in a 100 μL bolus once a day for 21 successive days. At the end of the AD treatment, animals are food deprived for one day and then measured for their latency to feed. 4-day treatment with Spadin significantly reduces the latency to feed when compared to saline or fluoxetine treatments.

Les statistiques affichées correspondent au cumul d'une part des vues des résumés de l'article et d'autre part des vues et téléchargements de l'article plein-texte (PDF, Full-HTML, ePub... selon les formats disponibles) sur la platefome Vision4Press.

Les statistiques sont disponibles avec un délai de 48 à 96 heures et sont mises à jour quotidiennement en semaine.

Le chargement des statistiques peut être long.